Toronto-based impact investor Cross Border Impact Ventures secured $58 million USD for a fund focused on women's and children's health.
Why it matters
Dedicated LP commitments to women's and children's health indicate growing specialized pool capital for healthtech startups outside traditional oncology or general digital health.
What to watch
Initial check sizes and geographic allocation of investments between North American and international healthtech targets.
Claryx raised $3.5 million USD to expand its hospital outbreak detection technology, prioritizing sales in the US market.
Why it matters
Canadian healthtech ventures increasingly target US hospital enterprise sales early in their lifecycle to achieve faster scale. Real-time pathogen and outbreak detection software aligns with hospital risk management priorities.
What to watch
Contract wins and pilot conversions inside US hospital systems.
Nova Scotia femtech startup Elle MD raised $1.1 million to develop a non-hormonal birth control ring ahead of upcoming clinical trials.
Why it matters
Non-hormonal women's health products address significant gaps in reproductive medicine. Early-stage funding is essential for seed-stage life science companies navigating pre-clinical regulatory approvals.
What to watch
Clinical trial outcome data and regulatory filing milestones with health authorities.